USA Today reports that one of the things that Amazon can bring to the table is "shipping products to consumers." True. But there's a problem. According to the article, "Since drug companies rely heavily on mail orders, Amazon's long-rumored entry in the pharamcy world could introduce price-lowering competition."
Good idea -- except that drug companies don't send a single pill to patients. That's the job of PBMs and insurance companies.
Maybe the Big Three (and and the media covering this story) should get a 100 level course in the pharmaceutival supply chain.